Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|November 18, 2018
Population pharmacokinetics of FOLFIRINOX: a review of studies and parametersLaure Deyme, Dominique Barbolosi, Florence GattaccecaCancer Chemotherapy and Pharmacology|April 29, 2021
Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimenLaure Deyme, Dominique Barbolosi, Litaty Céphanoée Mbatchi, et al.CPT: Pharmacometrics & Systems Pharmacology|April 1, 2024
Joint modeling of tumor dynamics and progression-free survival in advanced breast cancer: Leveraging data from amcenestrant early phase I-II trialsMarc Cerou, Hoai-Thu Thai, Laure Deyme, et al.Cancer Chemotherapy and Pharmacology|July 22, 2022
Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancerFabrice Barlesi, Laure Deyme, Diane-Charlotte Imbs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2024
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5Javier Cortés, Sara A Hurvitz, Joyce O'Shaughnessy, et al.Pageof 1